首页> 外文期刊>Reproductive biomedicine online >Probability of live birth in women with extremely low anti-Müllerian hormone concentrations
【24h】

Probability of live birth in women with extremely low anti-Müllerian hormone concentrations

机译:抗苗勒氏激素浓度极低的女性活产的可能性

获取原文
获取原文并翻译 | 示例

摘要

The aim of the present study was to investigate the clinical pregnancy and live birth rates in women with extremely low (≤0.4 ng/ml) anti-Müllerian hormone (AMH) concentrations. The study included 101 women (188 cycles) with extremely low AMH concentrations undergoing IVF cycles and compared the number of live births in women with low AMH. Moreover, the study compared the number of live births in women with or without endometriosis stage III/IV. Fourteen clinical pregnancies and 14 live births (including one pair of twins) were recorded; one woman miscarried. Significantly higher clinical pregnancy (P = 0.046) and live birth rates (P = 0.018) were found in women aged <35 years compared with older women. AMH concentration did not differ significantly between women with or without endometriosis and there were six live births in women with endometriosis. This was not significantly different from the rate in healthy women. It is concluded that live births are possible in women with extremely low AMH concentrations. The presence of endometriosis stage III/IV did not affect live birth rates in women with extremely low AMH concentrations although an important limitation of the study is the small number of women included who were affected by that disease. The aim of the present study was to investigate the clinical pregnancy and live birth rates in women with extremely low (≤0.4 ng/ml) anti-Müllerian hormone (AMH) concentrations. Moreover, we compared the number of live births in women with or without endometriosis stage III/IV. We concluded that, in women with extremely low AMH concentrations, live births are possible. The presence of endometriosis stage III/IV did not affect live birth rates in women with extremely low AMH concentrations, although the strong limitation of the study is that it included only a small number of women affected by that disease.
机译:本研究的目的是研究抗苗勒管激素(AMH)浓度极低(≤0.4 ng / ml)的女性的临床妊娠率和活产率。该研究包括101名妇女(188个周期),其接受IVF周期的AMH浓度极低,并比较了AMH较低的妇女的活产数量。此外,研究比较了有或没有子宫内膜异位症III / IV期妇女的活产数。记录了14例临床妊娠和14例活产(包括一对双胞胎)。一名妇女流产。与年龄较大的妇女相比,年龄<35岁的妇女的临床妊娠(P = 0.046)和活产率(P = 0.018)明显更高。在有或没有子宫内膜异位的女性中,AMH浓度无显着差异,子宫内膜异位的女性有6例活产。这与健康女性的比率没有显着差异。结论是,AMH浓度极低的妇女可以活产。内膜异位症III / IV期的存在并不影响AMH浓度极低的女性的活产率,尽管该研究的一个重要限制是受该病影响的女性人数很少。本研究的目的是调查抗苗勒管激素(AMH)浓度极低(≤0.4 ng / ml)的女性的临床妊娠率和活产率。此外,我们比较了有或没有子宫内膜异位症III / IV期妇女的活产数。我们得出的结论是,在AMH浓度极低的女性中,可以活产。内膜异位症III / IV期的存在并没有影响AMH浓度极低的妇女的活产率,尽管该研究的强项限制是它仅包括少数受该病影响的妇女。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号